• Gibberellin-Induced Autophagic Degradation of DELLA in Arabi

  2026-06-11

  This study reveals that gibberellin triggers ATG8-dependent autophagic degradation of DELLA proteins, a mechanism essential for seed germination and skotomorphogenesis under nutrient starvation in Arabidopsis. The findings expand the understanding of hormone-regulated protein turnover, demonstrating an alternative to 26S proteasome-mediated pathways and providing new avenues for investigating plant developmental responses to environmental stress.

• Amikacin Sulfate: Advancing Targeted Antibiotic Strategies i

  2026-06-11

  This thought-leadership article explores the evolving role of Amikacin Sulfate as a precision antibiotic for non-tuberculous mycobacterial infections. By integrating mechanistic insights, recent experimental advances, and translational strategy, it provides actionable intelligence for researchers to maximize the efficacy and safety of Amikacin-based interventions. The discussion is anchored by evidence from foundational studies and recent metagenomics discoveries, and is elevated beyond conventional product literature through a focus on intracellular pharmacokinetics, dendritic cell delivery, and emerging resistance landscapes.

• Crystal Violet Staining Solution: Precision in Colony and Mi

  2026-06-10

  Crystal Violet Staining Solution stands out as a reliable nuclear staining dye for both classical colony formation assays and advanced cell migration studies. With optimized protocols and robust troubleshooting strategies, this APExBIO product streamlines workflows for reproducible, high-contrast cellular analytics.

• Decoding Dual-Modality mRNA Tracking: EZ Cap Cy5 Firefly Luc

  2026-06-10

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) advances dual-modality mRNA tracking and translation efficiency, with novel insights into assay optimization and delivery system performance for gene therapy and mRNA vaccine research.

• TAI-1 Hec1 Inhibitor: Advanced Cancer Research Workflows

  2026-06-09

  TAI-1 sets a new benchmark for Hec1 inhibition, enabling precise disruption of mitotic regulation and potent induction of apoptotic cell death in diverse cancer models. This article presents actionable workflows, troubleshooting guidance, and evidence-based protocol enhancements to maximize TAI-1’s impact—especially in triple negative breast and liver cancer research.

• nor-NOHA Acetate: Precision Arginase Inhibition and Immune M

  2026-06-09

  Explore how nor-NOHA acetate enables advanced arginase inhibition in cancer research, with unique insights into immune modulation and metabolic interplay. This article offers an in-depth analysis and practical guidance for scientists seeking to leverage nor-NOHA’s full potential.

• CD36-Driven Lipid Metabolism Enables Immune Escape in AML

  2026-06-08

  Guo et al. reveal a non-canonical lipid metabolism program in acute myeloid leukemia (AML) in which CD36-mediated uptake of oxidized LDL and palmitate activates innate immune signaling, suppresses T cell proliferation, and confers resistance to hypomethylating therapy. Targeting the CD36 pathway, especially with statins, enhances decitabine efficacy, highlighting a new therapeutic vulnerability in AML.

• Temafloxacin: Fluoroquinolone Antibacterial Agent Workflows

  2026-06-08

  Temafloxacin stands out as a fluoroquinolone broad-spectrum antibacterial agent with robust, quantifiable activity against both Gram-positive and Gram-negative bacteria, as well as challenging intracellular pathogens. This article translates recent reference findings into actionable research workflows, troubleshooting strategies, and protocol enhancements for respiratory and intracellular infection models.

• Novobiocin: Aminocoumarin Antibiotic Workflows & Optimizatio

  2026-06-07

  Novobiocin offers researchers a unique dual-mechanism toolkit for tackling antibacterial resistance, antiparasitic, and antiviral challenges. This article delivers actionable workflows, protocol refinements, and troubleshooting tips for maximizing reproducibility and assay performance with APExBIO’s Novobiocin.

• Chemically Modified tRNA Boosts mRNA Translation Efficiency

  2026-06-06

  Dong et al. introduce a tRNA-plus strategy, demonstrating that overexpressed and chemically modified tRNAs can significantly enhance the translation and stability of mRNAs, especially those rich in cognate codons. Their results offer a generalizable approach for improving mRNA vaccine and therapeutic protein production.

• Dextran Sulfate Sodium Salt (MW 35000-45000): Dissecting Epi

  2026-06-05

  Explore how Dextran sulfate sodium salt (MW 35000-45000) uniquely enables mechanistic dissection of epithelial damage sensing and repair in preclinical colitis models. This article integrates cutting-edge insights into the GPR35-KLF5 circuitry, offering a new lens for optimizing ulcerative colitis research workflows.

• ECL Western Blotting Substrate: Technical Use and Workflow G

  2026-06-05

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of horseradish peroxidase (HRP) in protein analysis workflows such as Western blots. It is optimal for chemiluminescent detection in molecular biology, cancer biology, and signal transduction research, but should not be used for fluorescent or radioisotopic assays. Proper preparation, storage, and workflow discipline are essential for reliable results.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Interactio

  2026-06-04

  A recent study reveals that specific angiotensin peptide fragments, including N-terminally truncated forms, can significantly enhance the binding of the SARS-CoV-2 spike protein to alternative host receptors such as AXL. These findings offer new insights into renin-angiotensin pathway components as potential modulators of viral entry and may inform future research into cardiovascular–infectious disease cross-talk.

• (R,S)-Anatabine: Reliable Solutions for Alzheimer’s Assays

  2026-06-04

  (R,S)-Anatabine (SKU C4859) delivers consistent, data-backed results in cell-based and translational Alzheimer’s disease research. This article addresses common laboratory challenges—assay reproducibility, compound solubility, and mechanistic selectivity—demonstrating how (R,S)-Anatabine from APExBIO supports robust neurodegeneration workflows.

• gamma-Glu-Cys (γ-Glu-Cys): Protocols, QC, and Limitations

  2026-06-03

  gamma-Glu-Cys (γ-Glu-Cys) is an essential substrate for glutathione synthetase enzyme assays, serving as a critical intermediate in glutathione metabolism and peptide engineering. This compound is best suited for workflows requiring high-purity, well-characterized intermediates in glutathione pathway research and thiol-reactive peptide synthesis. It is not intended for diagnostic or clinical applications.

452 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page